Maggie Dingwall had to travel around 80 miles a day from her home near Richmond to James Cook University Hospital in ...

Stephen Bradley and his family received a great boost this week as his son Josh got the pleasure of ringing the cancer bell ...

UP to 5,000 men every year could avoid unnecessary cancer treatment, a charity says. Overtreatment can lead to side effects ...

One in every seven women will develop breast cancer during life, and the Very Pink Run is back to raise awareness and funds.

TNBC is one of the most aggressive and hard-to-treat types of breast cancer. Unlike other breast cancers, TNBC doesn’t have ...

Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by ...

Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields) therapy for the ...

The research was done in mice, where the fallopian tube is known as the uterine tube. Nikitin’s earlier studies had linked ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced the enrollment and dosing of the first patient in the pivotal Phase III clinical trial (AK104-310/COMPASSION-33) evaluating cadonilimab, a ...

Enright and Erik Sabrowski, a couple of resilient rookies, have rescued the group. The Guardians’ bullpen ranks fourth in the ...